mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.03 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |